TUBA1C and hepatocellular carcinoma: Notably, overexpression of TUBA1C, which is one of the α-tubulin subtypes is involved in the poor prognosis of HCC (Li et al., 2017), pancreatic ductal adenocarcinoma (Albahde et al., 2020), and lung cancer (Bian et al., 2021).